128 related articles for article (PubMed ID: 4459002)
1. The metabolic fate of levodopa in man and animals.
Louis WJ; Doyle AE; Sampson RG
Clin Exp Pharmacol Physiol; 1974; 1(4):341-6. PubMed ID: 4459002
[No Abstract] [Full Text] [Related]
2. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
Curtin F; Walker JP; Schulz P
J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
[TBL] [Abstract][Full Text] [Related]
3. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates.
Linnoila M; Oliver J; Adinoff B; Potter WZ
Arch Gen Psychiatry; 1988 Aug; 45(8):701-4. PubMed ID: 3395200
[TBL] [Abstract][Full Text] [Related]
4. The biochemistry of catecholamines in relation to Parkinson's disease.
Hinterberger H
Aust N Z J Med; 1971 May; 1():Suppl 1:14-8. PubMed ID: 5292808
[No Abstract] [Full Text] [Related]
5. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
6. Studies of catecholamine metabolism in two hereditary forms of dystonia.
Wotten GF; Eldridge R; Gordon EK; Axelrod J
Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
[No Abstract] [Full Text] [Related]
7. Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.
Turnbull MJ; Ballinger BR
Psychopharmacologia; 1973 May; 30(2):103-8. PubMed ID: 4711367
[No Abstract] [Full Text] [Related]
8. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
9. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
Piöchl E; Käser H; Klein H
Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB
Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit disorder symptoms and urine catecholamines.
Rogeness GA; Maas JW; Javors MA; Macedo CA; Fischer C; Harris WR
Psychiatry Res; 1989 Mar; 27(3):241-51. PubMed ID: 2469096
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine measurements in pheochromocytoma and neuroblastoma.
Spiegel HE
Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
[No Abstract] [Full Text] [Related]
13. State of adrenergic and cholinergic systems in schizophrenia patients during psychopharmacotherapy.
Krupenina LB; Vinogradov MV
Neurosci Behav Physiol; 1985; 15(1):1-8. PubMed ID: 3923387
[No Abstract] [Full Text] [Related]
14. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
Käser H; Türler K; Burri PH
Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
[No Abstract] [Full Text] [Related]
15. L-deprenyl treatment of on-off phenomena in Parkinson's disease.
Rinne UK; Siirtola T; Sonninen V
J Neural Transm; 1978; 43(3-4):253-62. PubMed ID: 745018
[No Abstract] [Full Text] [Related]
16. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
Linnoila M; Karoum F; Miller T; Potter WZ
Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia.
Paradisi R; Grossi G; Pintore A; Venturoli S; Porcu E; Capelli M; Flamigni C
Acta Endocrinol (Copenh); 1991 Sep; 125(3):246-52. PubMed ID: 1950338
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma: advances in diagnosis and treatment.
Pertsemlidis D; Gitlow SE; Kark AE
Surg Annu; 1972; 4():345-57. PubMed ID: 4589383
[No Abstract] [Full Text] [Related]
19. Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
van Praag HM
Compr Psychiatry; 1980; 21(1):44-54. PubMed ID: 6987035
[No Abstract] [Full Text] [Related]
20. [Effect of levodopa on the arterial pressure and the metabolism of catecholamines in essential hypertension].
Zaldívar HM; Monroy JR; Sánchez Torres G; Chávez Lara B; Serrano PA
Arch Inst Cardiol Mex; 1977; 47(5):591-603. PubMed ID: 603291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
